La cryothérapie peut aider à traiter avec succès les récidives de mésothéliomes.

Des radiologues de l'Université de Californie ont récemment démontré que la cryoablation peut détruires des cellules cancéreuses lors de récidives de mésothéliomes pleuraux.
Cryoablation is widely used to treat a number of cancers, such as prostate, liver or kidney cancer, but its efficiency with mesothelioma is still being tested. Recently, radiologists at UCLA (University of California, Los Angeles) showed that cryoablation can destroy tumour cells, through extreme cold, in patients with recurrent pleural mesothelioma. Some hospitals may offer this therapy to mesothelioma patients before or after surgery, on a palliative or curative basis. The procedure helps relieve the pain associated with mesothelioma, because it can shrink tumours that press against the lungs and other organs. It may also offer long-term management for local recurrences of the cancer.
Unlike other aggressive mesothelioma treatments, this procedure implies very few side effects. As it involves only local anaesthesia, patients can recover from the procedure very quickly.
This therapy consists in inserting probes into solid tumours and injecting cryotherapeutic agents such as liquid nitrogen into the diseased tissue. Cryotherapy allows radiologists to selectively destroy the cancerous tissue while leaving most healthy tissues undamaged.
Cryoablation is a safe form of mesothelioma treatment: it is less invasive than open surgery and requires a much shorter recovery time. Based on 110 mesothelioma cryoablation procedures performed at UCLA, the percentage of patients without recurrence was 92.5% after 6 months and 73.7% after 3 years. This technique is still underutilized today, but radiologists at UCLA try to spread the word about the efficiency of this treatment in patients with mesothelioma.

For further information, please consult this website.